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Abstract
We have previously generated a mouse model of spontaneous Th2-associated disease of
the small intestine called TRAF6ΔDC, in which dendritic cell (DC)-intrinsic expression of the
signaling mediator TRAF6 is ablated. Interestingly, broad-spectrum antibiotic treatment
ameliorates TRAF6ΔDC disease, implying a role for commensal microbiota in disease de-
velopment. However, the relationship between the drug effects and commensal microbiota
status remains to be formally demonstrated. To directly assess this relationship, we have
now generated TRAF6ΔDC bone marrow chimera mice under germ-free (GF) conditions
lacking commensal microbiota, and found, unexpectedly, that Th2-associated disease is
actually exacerbated in GF TRAF6ΔDCmice compared to specific pathogen-free (SPF)
TRAF6ΔDCmice. At the same time, broad-spectrum antibiotic treatment of GF TRAF6ΔDC
mice has an ameliorative effect similar to that observed in antibiotics-treated SPF
TRAF6ΔDCmice, implying a commensal microbiota-independent effect of broad-spectrum
antibiotic treatment. We further found that treatment of GF TRAF6ΔDCmice with broad-
spectrum antibiotics increases Foxp3+ Treg populations in lymphoid organs and the small
intestine, pointing to a possible mechanism by which treatment may directly exert an immu-
nomodulatory effect. To investigate links between the exacerbated phenotype of the small
intestines of GF TRAF6ΔDCmice and local microbiota, we performed microbiotic profiling
of the luminal contents specifically within the small intestines of diseased TRAF6ΔDCmice,
and, when compared to co-housed control mice, found significantly increased total bacterial
content characterized by specific increases in Firmicutes Lactobacillus species. These data
suggest a protective effect of Firmicutes Lactobacillus against the spontaneous Th2-related
inflammation of the small intestine of the TRAF6ΔDCmodel, and may represent a potential
mechanism for related disease phenotypes.
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Introduction
Immune homeostasis along the intestinal tract involves a delicate balance between protective
immunity to encountered pathogenic microorganisms and tolerance to commensal gut micro-
biota and other luminal antigens. Changes in either the microbiotic profile along mucosal bor-
ders, or in the manner in which microbiota-associated stimuli are interpreted by host cells can
lead to a variety of inflammatory diseases [1]. The intestinal tract is home to a vast array of spe-
cialized immune cells as well as absorptive and barrier cells, and the types and functions of
these cells change dramatically from the small intestine, where nutrient digestion and absorp-
tion occurs in the presence of a relatively low density of commensal microbiota, to the large in-
testine, where most water re-uptake occurs amongst the highest density and diversity of
commensal microbiota found in the body. Because of these anatomic and physiologic differ-
ences, inflammatory gut disease phenotypes presently identified are typically categorized ac-
cording to distinct intestinal regions, even if the specific mechanisms of cellular dysfunction
are not currently understood [2]. It is therefore important to develop and characterize animal
models that will enable better understanding of both the causes of inflammatory disease in the
small versus large intestine, and the role(s) of the interactions between extracellular stimuli,
such as commensal microbiota, and intestinal immune cells during the development of disease.
We have recently generated a new mouse model, TRAF6ΔDC [3], in which dendritic cell
(DC)-intrinsic expression of the signaling mediator TRAF6 is ablated, resulting in spontaneous
development of Th2-associated immune pathology and fibrosis of the small intestine. This pa-
thology is linked to decreased regulatory T cell (Treg) numbers in the small intestines of
TRAF6ΔDCmice [3]. The spontaneous nature of TRAF6ΔDC disease development, the Th2-
specific phenotype (as opposed to the predominantly Th1 phenotype of Crohn’s disease [2]),
and its relatively unusual localization to the small rather than large intestine—particularly the
proximal small intestine, for which there are no known models of spontaneous inflammation
[2]—make TRAF6ΔDC a unique and potentially powerful tool for studying intestinal immune
homeostasis. Therefore, more complete characterization of the mechanisms underlying
TRAF6ΔDC is required.
Inflammatory phenotypes in the gut are often linked to commensal microbiota [4], and in
fact, most conventional models of chronic intestinal inflammation are resolved when mice are
maintained under germ-free (GF) conditions, suggesting that stimuli from commensal micro-
biota are key factors in triggering disease [5,6]. Further, it has also been shown in the SAMP1/
YitFc mouse model of Crohn’s disease that spontaneous inflammation localized to the small in-
testine, in which only a minority of the commensal microbiotic population resides, is amelio-
rated with antibiotics treatment or maintenance under GF conditions [7,8]. Changes in the
composition of the commensal microbiota can lead to intestinal inflammation [9]. In our pre-
vious efforts, microbiotic profiling of total gut commensals revealed no remarkable disruption
of microbiotic homeostasis in TRAF6ΔDCmice; however, broad-spectrum antibiotic treat-
ment of TRAF6ΔDCmice resulted in near complete amelioration of spontaneous immune re-
sponses [3]. One possible explanation for this observation is abnormal processing of typical
microbiotic stimuli by TRAF6ΔDC intestinal cells, leading to pathogenic immunity. However,
it also remains possible that antibiotic treatment has microbiota-independent effects on im-
mune homeostasis that are relevant to the TRAF6ΔDC phenotype, and that this may be an im-
portant consideration for studying related disease phenotypes. In fact, other groups have
reported that antibiotics may have direct effects on immune homeostasis through modulation
of lymphocyte proliferation, cytokine elaboration, antibody production, and/or other ill-
defined immunosuppressive mechanisms [10–13]. Also, because most commensal microbiota
are found in the large intestine, while TRAF6ΔDC disease localizes to the small intestine, it is
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possible that disruption of microbiotic homeostasis may occur regionally in the small intestine,
which is a more acidic environment, thereby altering the extracellular signals received by the
local immune cells.
To dissect these issues we studied the TRAF6ΔDCmodel under GF conditions, i.e., in the
absence of commensal microbiota. In contrast to our expectation, we found that TRAF6ΔDC
gut immune pathology is exacerbated, not ameliorated, under GF conditions. Moreover, this
enhanced gut pathology could be ameliorated by broad-spectrum antibiotic treatment, which
appears to also enhance gut-associated Tregs in a microbiota-independent manner. Finally, we
identified local disruptions of microbiotic homeostasis in the TRAF6ΔDC small intestines,
which may suggest protective effects of certain commensal microbiota against spontaneous im-
mune pathology in the small intestine.
Materials and Methods
Animals
TRAF6ΔDCmice were generated by crossing mice carrying floxed alleles of Traf6 with CD11c-
Cre transgenic mice [3]. All mice were backcrossed to the C57BL/6 background more than twenty
generations. Eight control TRAF6 flx/flx mice (WT, no Cre) and 8 TRAF6ΔDCmice (ΔDC) were
used for small intestine bacteria taxonomic analysis and as donors for bone marrow chimeras.
Specific pathogen-free (SPF) C57BL/6 mice were purchased from Jackson Laboratory. Mice were
maintained under SPF conditions in the animal care facility at POSTECH. A colony of germ-free
(GF) C57BL/6 mice was established at POSTECH from breeders obtained fromDr. AndrewMac-
pherson (Bern Univ., Switzerland). Eighteen SPF C57BL/6 mice and 50 GF C57BL/6 mice were
used as recipients for bone marrow chimeras and antibiotic treatment experiments. All mice re-
ceived care in compliance with the protocols approved by the Institutional Animal Care and Use
Committees (IACUC) of the Pohang University of Science and Technology (2013–01–0012). GF
mice were maintained in sterile flexible film isolators (Class Biological Clean Ltd., USA) and GF
status was monitored monthly by anaerobic and aerobic culture of cecal contents. Normal chow
diet (2018S, Harlan Laboratories) and purified water were supplied after autoclaving. All mice
were humanely euthanized with CO2 before analysis or collecting cell populations.
Establishment of Bone Marrow Chimeras
For irradiation of GF mice, the mice were transferred to an autoclaved plastic cylinder sealed
with mylar film. The cylinder containing GF recipient mice was irradiated with a lethal dose of
950 cGy using X-RAD 320 (Precision X-ray, USA). After irradiation, the cylinder was con-
nected to the GF isolator and mice were transferred back to the isolator. SPF mice were irradi-
ated in a routine manner with the same dose. Bone marrow stem cells were isolated from tibias
and femurs of control TRAF6 flx/flx (WT, no Cre) or TRAF6ΔDC (ΔDC) mice and T cells
were removed by employing combined anti-CD4, anti-CD8, and anti-CD90.2 MACS depletion
(Miltenyi Biotec). The cells were transferred into autoclaved amber glass vials with silicone
caps and imported into GF isolator after sterilizing with 2% peracetic acid solution. 5 x 106
cells were transferred via retro-orbital injection into irradiated GF or SPF C57BL/6 recipient
mice. Chimeric mice were used for experiments upon hematopoietic reconstitution 6 to 8
weeks post bone marrow transplantation.
Cell Isolation
Single cells were isolated from spleens and mesenteric lymph nodes by mechanical disruption
on 70 μm cell strainers (BD). For the isolation of intestinal lamina propria lymphocytes,
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epithelial cells were removed by incubation in stripping buffer containing 3% FBS, 10 mM
EDTA, 1 mM sodium pyruvate, and 20 mMHEPES in PBS at 37°C for 15 min in shaker. The
remaining pieces were minced and incubated in 3% FBS RPMI-1640 medium containing 1 mg/
ml Collagenase D (Roche), 50 μg/ml DNaseI (Sigma), 1 mM sodium pyruvate, 1 mM non-
essential amino acid, and 20 mMHEPES at 37°C for 40 min in shaker. Mononuclear cells were
collected at the interface between 40% and 75% Percoll (GE Healthcare) after centrifuging at
2,500 rpm at room temperature for 20 min with no brake.
Histological Analysis
Intestinal specimens were cut longitudinally and shaped into inside-out Swiss rolls. Paraffin-
embedded sections were performed after fixation in 4% paraformaldehyde solution (Sigma).
Routine hematoxylin-eosin staining was performed using hematocylin for nucleus staining,
and eosin for cytoplasm and muscle layer.
Quantitative PCR
Tissues were homogenized in TRIzol (Invitrogen) after freezing in liquid nitrogen. cDNAs
were established by using QuantiTect Reverse Transcription Kit (QIAGEN). TaqMan gene
probes were used with TaqMan Universal PCR Master Mix (Applied Biosystems) and run on
ViiATM 7 Real-time PCR System (Applied Biosystems): 2 min at 50°C, 10 min at 95°C, 50 cy-
cles of 15 s 95°C, 1 min at 60°C, and signals were detected during annealing step (60°C). Rela-
tive mRNA expression levels of all samples were normalized to 18S mRNA. The TaqMan gene
probes (Applied Biosystems) used: Acta2 (Mm01546113_m1), Igf1 (Mm00439560_m1), Il13
(Mm99999190_m1), Il5 (Mm00439646_m1), Il4 (Mm00445259_m1), and 18S ribosomal RNA
(Hs99999901_s1).
Buffers and Media
FACS buffer containing 2% FBS and 0.7 mM EDTA was used to prepare, stain, and wash iso-
lated cells. Complete RPMI-1640 medium containing 10% FBS, 10 U/ml Penicillin, 10 mg/ml
Streptomycin, 2 mM L-glutamin (Invitrogen), and 50 mM b-mercapotethanol (Sigma) was
used for cell culture and stimulation.
Flow Cytometry
For intracellular staining, 106 cells were stimulated in round-bottom 96-well plates with com-
plete RPMI1640 medium containing 500 ng/ml ionomycin and 5 ng/ml PMA (Sigma) in the
presence of Brefeldin A (BD) for the last 3 hr. After surface staining with fluorochrome-
conjugated antibodies including CD4 (RM4–5), CD8 (53–6.7), and CD90.2 (53–2.1), the cells
were fixed and permeabilized with fixation/permeabilization reagent (eBioscience) and stained
with intracellular protein-specific antibodies specific for IL-13 (eBio13A), IFN-g (XMG1.2),
and Foxp3 (FJK-16 s). All stained samples were analyzed on an LSR Fortessa flow cytometer
(BD) and the raw data were calculated and visualized with FlowJo software (Tree Star). All of
the antibodies were purchased from eBioscience and Tonbo biosciences.
Antibiotic Treatment
Broad-spectrum antibiotic treatment was supplied for 2 weeks in drinking water containing
ampicillin (1 g/L, Sigma), vancomycin (0.5 g/L, Calbiochem), neomycin sulfate (1 g/L, Calbio-
chem), and metronidazole (1 g/L, Sigma). All antibiotic solutions were prepared by sterile by
0.2 μmmembrane filtration. The antibiotic solution was refreshed every 4 days.
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Small intestinal bacteria taxonomic analysis
Total DNA was isolated from small intestine contents (mostly from ileum) by using the Fas-
tDNA SPIN extraction kit (MP Biomedicals, Santa Ana, CA, USA) according to the manufac-
turer’s instructions. The deep sequencing analyses of bacterial composition including DNA
amplification, sequencing, and sequence analyses were performed by Chunlab, Inc. (Seoul,
Korea) as previously described [14]. Briefly, the target region of the 16S rRNA gene (V1–V3 of
variable region) was amplified by using barcoded fusion primers with a C1000 Touch thermal
cycler (Bio-Rad, Hercules, CA, USA). The amplified products were purified by the QIAquick
PCR purification kit (Qiagen, Valencia, CA, USA) and quantified by the PicoGreen dsDNA
Assay kit (Invitrogen, Carlsbad, CA, USA). The equimolar concentration of the amplicon from
each sample was pooled and sequencing performed on a Roche/454 GS Junior system accord-
ing to the manufacturer’s instructions.
Quantification of Gut Microbiota
Fecal pellets and small intestinal contents were collected from 8 week-old mice. Some groups
were fed by broad-spectrum antibiotic water (Abx) for 2–4 weeks. DNA was isolated from the
collected samples by using the PSP Spin Stool DNA Kit (Stratec molecular). Q-PCR was per-
formed with 16S rDNA probe. Copy numbers of bacteria were determined according to stan-
dard curves calculated from serially diluted E. coli. plasmid templates.
Statistics
Data were analyzed by using Prism software (GraphPad) with an unpaired or paired Student’s
t test. P values less than 0.05 were considered significant.
Ethics Statement
This research was approved by the Institutional Animal Care and Use Committees (IACUC) of
the Pohang University of Science and Technology (2013–01–0012). Mouse care and experi-
mental procedures were performed in accordance with all institutional guidelines for the ethi-
cal use of non-human animals in research and protocols from IACUC of the Pohang
University of Science and Technology.
Results
Germ-free conditions exacerbate Th2-associated immune pathology in
TRAF6ΔDC small intestine
We have previously shown that broad-spectrum antibiotic treatment ameliorates spontaneous
Th2-associated disease in TRAF6ΔDCmice. However, the relationship between the drug effects
and commensal microbiota status remains unclear. Therefore, we have established TRAF6ΔDC
bone marrow chimera mice under GF conditions. We anticipated that GF TRAF6ΔDCmice
would recapitulate the effects of antibiotic treatment since antibiotics are widely used to mimic
GF conditions by broadly ablating gut commensal bacteria. Contrary to our expectation, GF
TRAF6ΔDC bone marrow chimeras did not phenocopy antibiotic-treated TRAF6ΔDC specific
pathogen-free (SPF) mice, but instead exhibited exacerbated gut phenotypes including gross ap-
pearance (Fig. 1A) and histology (Fig. 1B), as well as increased Th2 cytokine-producing cells
(Fig. 2A and B). Elevated serum IgE levels (Fig. 2C) in GF TRAF6ΔDC bone marrow chimeras
were consistent with observations of exacerbated gut inflammation. Furthermore, small intes-
tine tissue gene expression levels of pro-fibrotic markers (Acta2 and Igf-1) and Th2 cytokines
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(IL-13, IL-5, and IL-4) were increased in GF TRAF6ΔDC bone marrow chimeras compared to
SPF TRAF6ΔDCmice (Fig. 2D). Together, these findings imply that microbiota may actually
play some positive role in maintain gut immune homeostasis in TRAF6ΔDCmice.
Broad-spectrum antibiotics ameliorate TRAF6ΔDC immune pathology
exacerbated by GF conditions
The exacerbated disease phenotype observed in GF TRAF6ΔDC bone marrow chimeras sug-
gested that antibiotics-mediated disease amelioration might not be microbiota-dependent. To
determine if antibiotics function independently of gut microbiota in the context of immune pa-
thology in the TRAF6ΔDCmodel, broad-spectrum antibiotics were administered orally to GF
TRAF6ΔDC bone marrow chimeras at 6 weeks post-reconstitution for two weeks prior to phe-
notyping. Interestingly, Th2 cytokine-producing cells were reduced in GF TRAF6ΔDC bone
marrow chimeras when treated with antibiotics (Fig. 3A and B). Length and mass of small in-
testines were reduced in antibiotics-treated GF TRAF6ΔDCmice (Fig. 3C), as were small intes-
tine gene expression levels of both fibrotic markers and Th2 cytokines (Fig. 3D). These data
suggest that broad-spectrum antibiotics may directly suppress TRAF6ΔDC Th2-associated gut
inflammation in a manner independent of gut microbiota.
Fig 1. Germ-free conditions exacerbate inflammation of TRAF6ΔDC small intestine. (A) Representative gut images from control (WT) and TRAF6ΔDC
(ΔDC) bone marrow chimera established in specific pathogen free (SPF) or germ-free (GF) condition at 8 weeks post-reconstitution. (B) Histological analyses
were performed by H&E staining of duodenum from each mice. Scale bars represent 100 μm. (C) Lengths and masses of small intestines and colons were
measured in control (WT) and TRAF6ΔDC (ΔDC) bone marrow chimera (n = 6). SPF, specific pathogen free; GF, germ-free. *p< 0.05; **p< 0.01; ***p<
0.001; ****p< 0.0001.
doi:10.1371/journal.pone.0118795.g001
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Increased Tregs in GF TRAF6ΔDC lymphoid organs following antibiotic
treatment
We have previously reported rescue of the small intestine Treg population in TRAF6ΔDCmice
treated with broad-spectrum antibiotics [3]. Therefore, we hypothesized that antibiotic treat-
ment of GF TRAF6ΔDCmice would similarly enhance the Treg population. Since we cannot
isolate cells from TRAF6ΔDC small intestines once severe fibrosis sets in, spleens and mesen-
teric lymph nodes were analyzed instead (Fig. 4A and B). Increased Treg cells were observed in
GF TRAF6ΔDC lymphoid organs at 8 weeks post-reconstitution after antibiotic water treat-
ment for last two weeks (Fig. 4A and B). Interestingly, we also observed increased Treg num-
bers in control GF mice receiving similar antibiotics treatment (Fig. 4C). These findings
suggest a general direct positive microbiota-independent effect of broad-spectrum antibiotic
treatment on Treg populations, either by recruitment and/or proliferation, in the lymphoid or-
gans and peripheral tissues. Further, this effect may be relevant to maintaining immune ho-
meostasis of the TRAF6ΔDC small intestine.
TRAF6ΔDCmice exhibit disruption of microbiotic homeostasis localized
to the small intestine
We previously reported that there are no apparent differences in the microbiotic profiles of fecal
material collected from TRAF6ΔDCmice and co-housed control mice. To better understand
why GF conditions exacerbated the pathologic phenotype of TRAF6ΔDCmice, we performed
microbiotic profiling of the luminal contents specifically within the small intestines of diseased
Fig 2. Germ-free conditions exacerbate Th2-associated immune pathology in TRAF6ΔDC small intestine. (A and B) Increases of IL-13+ cells in
mesenteric lymph nodes of TRAF6ΔDC (ΔDC) bone marrow chimera in germ-free (GF) condition compared to specific pathogen free (SPF) condition. The
representative FACS plots gated on CD4 T cells of mesenteric lymph nodes show intracellular staining for interferon-γ (IFN-γ) and IL-13. (C) Serum
immunoglobulin levels in the chimera were measured by ELISA. (D) Fibrosis markers (Acta2 and Igf-1) and Th2 cell cytokines (IL-13, IL-5, and IL-4) mRNA
expression levels in the ileum region of small intestines from SPF or GF control and TRAF6Δ bone marrow chimera. Histograms (mean ± SD) are
representative of three independent experiments. *p< 0.05; **p< 0.01.
doi:10.1371/journal.pone.0118795.g002
Spontaneous Gut Inflammation Model in a Germ-Free Environment
PLOS ONE | DOI:10.1371/journal.pone.0118795 February 17, 2015 7 / 13
TRAF6ΔDCmice or co-housed control mice. Total genomic DNA was isolated from small intes-
tine luminal contents in ileal sections of control and TRAF6ΔDCmice, and metagenomic analy-
ses were performed to determine any differences in bacterial communities. Interestingly, the
bacterial composition of the TRAF6ΔDC small intestine differs from control, specifically with re-
spect to the phylum Firmicutes, which was dramatically increased, while Bacteroidetes was de-
creased (Fig. 5A). Heatmap analyses further details these differences (Fig. 5B), showing strongly
increased Lactobacillus in the TRAF6ΔDC small intestine compared to other bacteria. To clarify
the factors leading to altered bacterial composition, total bacterial copy number was quantified
using PCR for bacterial 16S rRNA (Fig. 5C). Even though relative copy number of bacterial 16S
rRNA in the small intestine is much lower than for colon contents or feces, significant increases
in copy number in TRAF6ΔDC small intestines were observed. Taken together, dramatically
Fig 3. Broad-spectrum antibiotics ameliorate TRAF6ΔDC immune pathology exacerbated by GF conditions. (A) FACS plots gated on CD4+ T cells
show intracellular staining for interferon-γ (IFN-γ) and IL-13 from each indicated organ of TRAF6ΔDC bone marrow chimera (ΔDC-BMC) in germ-free (GF)
condition at 8 weeks post-reconstitution. Some of TRAF6ΔDC bone marrow chimeras (ΔDC) were provided with broad-spectrum antibiotic water (Abx). The
antibiotic water, containing 1 g/L Ampicillin, 1 g/L Neomycin, 0.5 g/L Vancomycin, and 1 g/L Metronidazole, was provided ad libitum in water to TRAF6ΔDC
bone marrow chimera (ΔDC) for last 2 weeks. (B) Percentage of IL-13+ CD4 T cells were shown in each organs of TRAF6ΔDC bone marrow chimera (ΔDC-
BMC) in germ-free (GF) or germ-free under antibiotics (GF-Abx). (C) Lengths and masses of small intestines were measured in GF and GF-Abx TRAF6ΔDC
bone marrow chimera (ΔDC-BMC). (D) Fibrosis markers (Acta2 and Igf-1) and Th2 cell cytokines (IL-13, IL-5, and IL-4) mRNA expression levels in the ileum
region of small intestines from GF and GF-Abx TRAF6ΔDC bone marrow chimera (ΔDC-BMC). Histograms (mean ± SD) are representative of four
independent experiments. SP, spleen; MLN, mesenteric lymph node. *p< 0.05; **p< 0.01; ***p< 0.001.
doi:10.1371/journal.pone.0118795.g003
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Fig 4. Increased Tregs in GF TRAF6ΔDC lymphoid organs following antibiotic treatment. (A) FACS plots gated on CD4+ T cells show intracellular
staining Foxp3 from each indicated organ of germ-free (GF) TRAF6ΔDC bone marrow chimera (ΔDC-BMC) at 8 weeks post-reconstitution. Broad-spectrum
antibiotic water was provided to a group of TRAF6ΔDC bone marrow chimeras (ΔDC) for the last 2 weeks. (B) Percentage of Foxp3+ CD4 T cells were
determined from the indicated organs of TRAF6ΔDC bone marrow chimera (ΔDC-BMC) in germ-free (GF) or germ-free under antibiotics (GF-Abx).
(C) Representative FACS plots show Foxp3+ CD4 T cells from each indicated organ of germ-free (GF) B6 mice. Some of the mice were provided with broad-
spectrum antibiotic water (GF-Abx) for last 2 weeks. Percentage of Foxp3+ CD4 T cells were shown in each organs of germ-free B6 mice with (GF-Abx) or
without antibiotics (GF). SP, spleen; MLN, mesenteric lymph node; SI, small intestine; COL, colon. **p< 0.01.
doi:10.1371/journal.pone.0118795.g004
Spontaneous Gut Inflammation Model in a Germ-Free Environment
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Fig 5. TRAF6ΔDCmice exhibit disruption of microbiotic homeostasis localized to the small intestine.
(A) Pie charts represent bacterial composition categorized by phylum in the small bowl of control (WT) or
TRAF6ΔDC (ΔDC) mice. (B) Heatmap analysis shows relative abundance of taxa as a percentage of total
16S rRNA, organized according to genus or most specific assigned taxon. Color scales reflect proportion
contributed by each taxon. Total bacterial genome was isolated from small intestinal contents of control (WT)
Spontaneous Gut Inflammation Model in a Germ-Free Environment
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increased bacterial quantity in TRAF6ΔDC small intestines is explained by elevation of the phy-
lum Firmicutes, especially the genus Lactobacillus, which may imply a protective effect of Firmi-
cutes Lactobacillus in the context of controlling TRAF6ΔDC Th2-associated disease.
Discussion
Inflammatory autoimmune and allergic diseases of the intestine are of great interest both be-
cause of their clinical prevalence and because they result from manifold triggers and underlying
causes, most of which are not fully understood. There is also great variability in disease mani-
festation depending on specific anatomic location, types and activation status of immune cells
involved, and lastly, but importantly, how host intestinal cells interact with commensal micro-
biota of the gut. Because of these many variables, it has been important to develop and charac-
terize robust animal models that accurately represent specific human diseases. In this study we
have substantially clarified the host-microbiota relationship and causes of spontaneous small
intestine immune pathology in the TRAF6ΔDCmouse model. Specifically, and most impor-
tantly, we have shown that broad-spectrum antibiotic treatment of TRAF6ΔDCmice does not
primarily exert its disease ameliorating effects by ablating gut microbiota. We have further
shown that antibiotic treatment may, under certain circumstances, increase Treg numbers
and/or recruitment, which differs from other studies of the effects of antibiotics that focus on
colonic Treg cells [15]. Because TRAF6ΔDC is a model based on altering DC function, it may
be useful in the future to investigate the direct role of antibiotics treatment on DC function in
order to understand how the TRAF6ΔDC phenotype manifests and to better recognize what ef-
fects antibiotics may have on DC function in a clinical setting. Additionally, given our findings
regarding modulation of Treg status by antibiotics in the absence of microbiota, we must deter-
mine whether ablation of the Treg population by antibody or genetic approaches causes re-
establishment of any or all components of disease in antibiotics-treated SPF and/or GF
TRAF6ΔDCmice. This would further confirm how broad-spectrum antibiotics regulate im-
mune function independently of microbiota in the small intestine.
We determined that GF conditions exacerbated TRAF6ΔDC disease, and by further finding
increased Lactobacillus localized to the small intestines of TRAF6ΔDCmice, we speculate that
these strains provide a protective effect against TRAF6ΔDC inflammatory disease since their
removal under GF conditions actually exacerbates disease. In order to confirm this protective
effect, it will be important to generate gnotobiotic TRAF6ΔDCmice that specifically contain
Firmicutes Lactobacillus strains to interrogate whether the GF-enhanced disease phenotype in
TRAF6ΔDCmice is ameliorated. Lactobacillus species have been well known to possess anti-
inflammatory properties in the context of commensal microbiota homeostasis of the large in-
testine [16], and have been employed in the prevention of inflammatory bowel disease [17,18].
While the levels of commensal bacteria are at least 1000 fold higher in the large intestine than
the small intestine, where TRAF6ΔDC disease occurs, significant levels of colonization are
found in the ileum, where counts can be as high as 108 CFU/mL [1,19]. It is also notable that
under inflammatory conditions, concentrations of reactive oxygen species in the gut are often
increased [20], creating a more aerobic environment, which may affect the composition of the
gut microbiota. Lactobacillus species, though anaerobic, can survive well under aerobic
or TRAF6ΔDC (ΔDC) mice (n = 4, 20 week old littermate and co-housed group). (C) The copy number of total
bacterial 16S rRNA bacteria from fecal or small intestine contents of control (WT) and TRAF6ΔDC (ΔDC) was
measured by comparing to reference E. coli 16S rRNA plasmids. Some groups were fed by broad-spectrum
antibiotic water (Abx) for last 2 weeks before collecting samples. **p< 0.001; n.s., not significant. Data were
analyzed by Anova on Prism software (n = 3).
doi:10.1371/journal.pone.0118795.g005
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conditions and have a relatively high tolerance for reactive oxygen species, such as hydrogen
peroxide (H2O2) [21]. The increased levels of Lactobacillus detected in the TRAF6ΔDC small
intestine raise questions as to whether changes in TRAF6ΔDCmicrobiotic composition are a
reaction to incipient inflammation, or rather occur in parallel due to altered biology of TRAF6-
deficient DCs in the gut. For instance, there is reported evidence that TLR signaling in macro-
phages regulates reactive oxygen species production in a TRAF6-dependent manner [22]. It
may be useful to determine whether TRAF6ΔDC small intestinal DCs have a higher propensity
for producing reactive oxygen species that may alter gut microbiota composition, and further,
whether directly manipulating oxygenation of the TRAF6ΔDC gut affects microbiotic compo-
sition and/or inflammatory disease of the small intestine.
The fact that we observed exacerbated inflammatory disease in GF versus SPF TRAF6ΔDC
mice suggests that regardless of the specific direct immunomodulatory effects of broad-spectrum
antibiotics treatment, or the potential immunosuppressive role of Lactobacillus, the trigger and/
or antigenic driver of TRAF6ΔDC inflammatory disease is microbiota-independent. While this
finding was not predicted given previous results using only broad-spectrum antibiotics under
SPF conditions, it may not be surprising given the relatively low bacterial load in the small intes-
tine (compared to the large intestine) where disease is localized. Therefore, in order to fully char-
acterize the nature of inflammatory disease in the TRAF6ΔDCmodel, we must consider
alternative triggers of spontaneous immune pathology in TRAF6ΔDCmice. Because of the key
role of the small intestine in digesting and absorbing dietary material, it is possible that disease is
triggered by food-related antigen. Moreover, the current work also suggests that microbiota in-
teractions with foodstuff are not required for disease induction. In either case, these possibilities
must be further investigated, for instance by modulating dietary intake of TRAF6ΔDCmice
under GF and SPF conditions, because a positive finding may identify TRAF6ΔDC as an ex-
tremely valuable genetic model for food antigen-related immune pathology and/or allergy.
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